Enbrel

(800) 889-3898

Enbrel was on the market for just five months with reports of thirty patients treated with Enbrel developing serious infections including sepsis. As a result, on May 12, 1999 the FDA announced a new warning would be put on Enbrel arthritis drug labeling. When the warning label was issued there had been 25,000 patients treated with and six of these patients died within two to 16 weeks after beginning Enbrel.

Enbrel was approved to relieve rheumatoid arthritis joint swelling pain, as well as other symptoms. Most commonly, infections included upper respiratory infections and sinusitis. If you have suffered from the use of Enbrel and would like to learn your legal rights and options, please
contact us.


Free Consultation Use this form to request a free consultation with a qualified attorney near you.

Note: The use of the Internet for communications with the firm will not establish an attorney-client relationship and messages containing confidential or time-sensitive information should not be sent. I agree that submitting this form does not create an attorney-client relationship and that the information I am providing may be used to check for conflicts of interest to determine if the firm can assist me with my legal inquiry. I Agree:*

ATTORNEY ADVERTISING
Flood Law Group, LLP
1101 Pennsylvania Avenue, Suite 600
Washington, DC 20004
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private
FREE